A potent inhibitor of GCP II/NAALADase
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

2-(Phosphonomethyl)-pentanedioic Acid

Item No. 21916

Technical Information
Formal Name
2-(phosphonomethyl)-pentanedioic acid
CAS Number
173039-10-6
Synonyms
  • 2-PMPA
Molecular Formula
C6H11O7P
Formula Weight
Purity
≥95%
Formulation
A crystalline solid
PBS (pH 7.2): 10 mg/ml
SMILES
OP(CC(C(O)=O)CCC(O)=O)(O)=O
InChi Code
InChI=1S/C6H11O7P/c7-5(8)2-1-4(6(9)10)3-14(11,12)13/h4H,1-3H2,(H,7,8)(H,9,10)(H2,11,12,13)
InChi Key
ISEYJGQFXSTPMQ-UHFFFAOYSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Add

    Product Description

    2-(Phosphonomethyl)-pentanedioic acid (2-PMPA) is a potent inhibitor of glutamate carboxypeptidase II (GCP II), also known as N-acetylated α-linked dipeptidase (NAALADase), with a Ki value of 98 pM for release of glutamate from the NAALADase peptide substrate N-acetylasparatylglutamate (NAAG).1 It is selective for GCP II/NAALADase over a panel of 100 receptors, transporters, ion channels, and enzymes at a concentration of 10 μM.2 2-PMPA is neuroprotective against hypoxia (EC50 = 8.4 μM), but not veratridine-induced injury, in neuron-enriched primary cultures from rat embryo cerebellum.3 In vivo, 2-PMPA reduces neuronal cell death induced by middle cerebral artery occlusion via increases in NAAG expression and reduction of glutamate in rats.2 2-PMPA (100 mg/kg) blocks the conditioned place preference response to cocaine, but not food, in male rats.4 It reduces the number of flinches induced by formalin injection into the footpad of mice when administered at a dose of 10 μg per animal, an effect that is reversed by the group II metabotropic glutamate receptor antagonist LY341495.5 2-PMPA also decreases severity and delays onset of experimental autoimmune encephalomyelitis (EAE) in mice.6

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Luthi-Carter, R., Barczak, A.K., Speno, H., et alHydrolysis of the neuropeptide N-acetylaspartylglutamate (NAAG) by cloned human glutamate carboxypeptidase II. Brain Res. 795(1-2), 341-348 (1998).

    2. Slusher, B.S., Vornov, J.J., Thomas, A.G., et alSelective inhibition of NAALADase, which converts NAAG to glutamate, reduces ischemic brain injury. Nat. Med. 5(12), 1396-1402 (1999).

    3. Tortella, F.C., Lin, Y., Ved, H., et alNeuroprotection produced by the NAALADase inhibitor 2-PMPA in rat cerebellar neurons. Eur. J. Pharmacol. 402(1-2), 31-37 (2000).

    4. Slusher, B.S., Thomas, A., Paul, M., et alExpression and acquisition of the conditioned place preference response to cocaine in rats is blocked by selective inhibitors of the enzyme N-acetylated-α-linked-acidic dipeptidase (NAALADASE). Synapse 41(1), 22-28 (2001).

    5. Yamamoto, T., Kozikowski, A., Zhou, J., et alIntracerebroventricular administration of N-acetylaspartylglutamate (NAAG) peptidase inhibitors is analgesic in inflammatory pain. Mol. Pain 4:31, (2008).

    6. Ha, D., Bing, S.J., Ahn, G., et alBlocking glutamate carboxypeptidase II inhibits glutamate excitotoxicity and regulates immune responses in experimental autoimmune encephalomyelitis. FEBS J. 283(18), 3438-3456 (2016).